Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Pipeline Therapeutics
company
About
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $32M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases. The company's therapies leverage the natural repair process in several different nervous system cell types to target diseases such as multiple sclerosis, providing patients with a treatment to repair damage to the nervous system.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$112M
Pipeline Therapeutics has raised a total of
$112M
in funding over 2 rounds. Their latest funding was raised on
Feb 11, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 11, 2021 | Series C | $80M | 1 | — | — | Detail |
| Dec 18, 2019 | Series B | $32M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Pipeline Therapeutics is funded by 1 investors.
Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Versant Ventures
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
